Nutex Health (NUTX) Expected to Announce Quarterly Earnings on Thursday

Nutex Health (NASDAQ:NUTX) is projected to issue its Q4 2025 results after the market closes on Thursday, March 5th. Analysts expect the company to announce earnings of $5.56 per share and revenue of $258.8160 million for the quarter. Parties can check the company’s upcoming Q4 2025 earning summary page for the latest details on the call scheduled for Friday, March 6, 2026 at 10:30 AM ET.

Nutex Health Stock Performance

Shares of NASDAQ:NUTX traded down $4.33 during mid-day trading on Friday, reaching $111.45. The company had a trading volume of 51,495 shares, compared to its average volume of 187,059. The company has a current ratio of 3.20, a quick ratio of 3.18 and a debt-to-equity ratio of 0.67. The company’s 50-day moving average price is $144.48 and its 200-day moving average price is $124.12. Nutex Health has a one year low of $40.67 and a one year high of $193.07. The firm has a market cap of $787.92 million, a price-to-earnings ratio of 6.03 and a beta of -0.01.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on the company. Weiss Ratings reissued a “hold (c)” rating on shares of Nutex Health in a report on Monday, December 29th. Wall Street Zen raised Nutex Health from a “buy” rating to a “strong-buy” rating in a research note on Friday, November 28th. Two investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat, Nutex Health currently has a consensus rating of “Moderate Buy” and an average price target of $252.50.

Hedge Funds Weigh In On Nutex Health

Large investors have recently bought and sold shares of the stock. Pertento Partners LLP boosted its stake in shares of Nutex Health by 20.0% during the fourth quarter. Pertento Partners LLP now owns 324,422 shares of the company’s stock valued at $53,406,000 after purchasing an additional 54,001 shares during the period. Topline Capital Management LLC boosted its position in Nutex Health by 72.0% during the 2nd quarter. Topline Capital Management LLC now owns 309,131 shares of the company’s stock valued at $38,484,000 after buying an additional 129,418 shares during the period. Vanguard Group Inc. grew its holdings in Nutex Health by 12.7% in the 3rd quarter. Vanguard Group Inc. now owns 214,954 shares of the company’s stock worth $22,209,000 after acquiring an additional 24,275 shares during the last quarter. Millennium Management LLC increased its position in shares of Nutex Health by 191.1% in the third quarter. Millennium Management LLC now owns 93,396 shares of the company’s stock valued at $9,650,000 after acquiring an additional 61,308 shares during the period. Finally, State Street Corp raised its stake in shares of Nutex Health by 11.6% during the fourth quarter. State Street Corp now owns 86,792 shares of the company’s stock valued at $14,288,000 after acquiring an additional 9,052 shares during the last quarter. 5.32% of the stock is owned by hedge funds and other institutional investors.

About Nutex Health

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.